270 related articles for article (PubMed ID: 9107388)
1. Safety of chloramphenicol eyedrops.
Firkin F; Campbell T
Aust N Z J Ophthalmol; 1997 Feb; 25(1):3. PubMed ID: 9107388
[No Abstract] [Full Text] [Related]
2. Chloramphenicol-induced aplastic anaemia--should its topical use be abandoned?
Tan LK
Singapore Med J; 1999 Jul; 40(7):445-6. PubMed ID: 10560268
[No Abstract] [Full Text] [Related]
3. Topical chloramphenicol for eye infections.
Lam RF; Lai JS; Ng JS; Rao SK; Law RW; Lam DS
Hong Kong Med J; 2002 Feb; 8(1):44-7. PubMed ID: 11861993
[TBL] [Abstract][Full Text] [Related]
4. It is time to stop using topical chloramphenicol.
Smith JR; Wesselingh S; Coster DJ
Aust N Z J Ophthalmol; 1997 Feb; 25(1):83-8. PubMed ID: 9107404
[No Abstract] [Full Text] [Related]
5. Aplastic anemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature.
Issaragrisil S; Piankijagum A
J Med Assoc Thai; 1985 Jun; 68(6):309-12. PubMed ID: 4056637
[No Abstract] [Full Text] [Related]
6. Restricting topical ocular chloramphenicol eye drop use in the United States. Did we overreact?
Fraunfelder FW; Fraunfelder FT
Am J Ophthalmol; 2013 Sep; 156(3):420-422. PubMed ID: 23953152
[No Abstract] [Full Text] [Related]
7. Ocular chloramphenicol and aplastic anaemia. Is there a link?
Rayner SA; Buckley RJ
Drug Saf; 1996 May; 14(5):273-6. PubMed ID: 8800624
[TBL] [Abstract][Full Text] [Related]
8. [Local treatment with chloramphenicol].
Warnecke J; Fehrs W
Hautarzt; 1998 Jan; 49(1):55. PubMed ID: 9522194
[No Abstract] [Full Text] [Related]
9. [Systemic side effects due to external application of chloramphenicol].
Hautarzt; 1985 Mar; 36(3):181-3. PubMed ID: 3997517
[No Abstract] [Full Text] [Related]
10. Marrow aplasia following topical application of chloramphenicol eye ointment.
Abrams SM; Degnan TJ; Vinciguerra V
Arch Intern Med; 1980 Apr; 140(4):576-7. PubMed ID: 7362398
[TBL] [Abstract][Full Text] [Related]
11. Chloramphenicol and aplastic anemia.
Flach AJ
Am J Ophthalmol; 1982 May; 93(5):664-6. PubMed ID: 7081370
[No Abstract] [Full Text] [Related]
12. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia?
McGhee CN; Anastas CN
Br J Ophthalmol; 1996 Feb; 80(2):182-4. PubMed ID: 8814753
[TBL] [Abstract][Full Text] [Related]
13. The fall and rise of chloramphenicol.
Isenberg SJ
J AAPOS; 2003 Oct; 7(5):307-8. PubMed ID: 14566309
[No Abstract] [Full Text] [Related]
14. [Chloramphenicol in ophthalmic instillation and risk of generalized sensitization].
Verin P; Sekkat A; Morax S
Bull Soc Ophtalmol Fr; 1972 Mar; 72(3):365-70. PubMed ID: 4643424
[No Abstract] [Full Text] [Related]
15. Topical administration of chloramphenicol can induce acute hepatitis.
Doshi B; Sarkar S
BMJ; 2009 Jun; 338():b1699. PubMed ID: 19525305
[No Abstract] [Full Text] [Related]
16. Use of chloramphenicol as topical eye medication: time to cry halt?
Doona M; Walsh JB
BMJ; 1995 May; 310(6989):1217-8. PubMed ID: 7767184
[No Abstract] [Full Text] [Related]
17. Ocular chloramphenicol and aplastic anemia.
Fraunfelder FT; Bagby GC
N Engl J Med; 1983 Jun; 308(25):1536. PubMed ID: 6855828
[No Abstract] [Full Text] [Related]
18. Is it time to stop using chloramphenicol on the eye? Risk is low in short courses.
Hall AV; Das SS; Tabaqchali S
BMJ; 1995 Aug; 311(7002):450-1; author reply 451. PubMed ID: 7640599
[No Abstract] [Full Text] [Related]
19. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies.
Wiholm BE; Kelly JP; Kaufman D; Issaragrisil S; Levy M; Anderson T; Shapiro S
BMJ; 1998 Feb; 316(7132):666. PubMed ID: 9522791
[No Abstract] [Full Text] [Related]
20. Widespread use of topical chloramphenicol.
Ursell P
Br J Ophthalmol; 1996 Sep; 80(9):854. PubMed ID: 8942390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
